Please enter the email address you used to register, then we will send you a link to choose a new password
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 ...
Emergent BioSolutions Inc. (NYSE:EBS) today announced it has received a $30 million contract modification from the Biomedical A...
-SEC Filing
Emergent BioSolutions (NYSE:EBS) narrows FY2025 sales outlook from $750.00 million-$850.00 million to $765.00 million-$835.00 m...
Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $(...
Emergent BioSolutions Inc. (NYSE:EBS) today announced the publication of a comprehensive review article, "Brincidofovir in ...